"As your partner in health, we’re dedicated to making it easier for you to live well—so you can show up for the moments that matter most. To us, people are more than patients. We work together as a team to champion high-quality, low-cost care. Our providers and services span hospitals, clinics and at home settings across Iowa, Illinois and Wisconsin. Our presence in metropolitan and rural communities allows us to innovate through partnerships, organizations outside of healthcare, and our family of team members remains dedicated to shared values that put our people first. Because you matter to this world, and we’ll show you just how much."

During the past decade, McFarland Clinic PC-Trinity Cancer Center conducted 140 clinical trials. In the 10-year time frame, 140 clinical trials started and 46 clinical trials were completed, i.e. on average, 32.9% percent of trials that started reached the finish line to date. In the past 5 years, 80 clinical trials started and 40 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McFarland Clinic PC-Trinity Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 80 trials, followed by "SWOG Cancer Research Network" with 38 trials sponsored, "Alliance for Clinical Trials in Oncology" with 25 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "NRG Oncology" with 16 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McFarland Clinic PC-Trinity Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 87 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "McFarland Clinic PC-Trinity Cancer Center" are "Stage IV Lung Cancer AJCC v8" (11 trials), "Invasive Breast Carcinoma" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IVA Lung Cancer AJCC v8" (8 trials) and "Stage IVB Lung Cancer AJCC v8" (8 trials). Many other conditions were trialed in "McFarland Clinic PC-Trinity Cancer Center" in a lesser frequency.

Most popular intervention types in "McFarland Clinic PC-Trinity Cancer Center" are "Drug" (137 trials), "Other" (104 trials), "Biological" (77 trials), "Procedure" (52 trials) and "Radiation" (12 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (47 trials), "Laboratory Biomarker Analysis" (46 trials), "Questionnaire Administration" (32 trials), "Biospecimen Collection" (31 trials) and "Computed Tomography" (31 trials). Other intervention names were less common.

The vast majority of trials in "McFarland Clinic PC-Trinity Cancer Center" are 146 trials for "All" genders, 19 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "McFarland Clinic PC-Trinity Cancer Center". undefined are not yet recruiting, 66 are recruiting, 74 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in McFarland Clinic PC-Trinity Cancer Center, 3 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in McFarland Clinic PC-Trinity Cancer Center, 3 "Phase 1" clinical trials were conducted, 91 "Phase 2" clinical trials and 84 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".